obesity
Conditions
Interventions
In addition to distributing a pamphlet created by a registered dietitian from the health screening division who is responsible for specific health guidance during workplace health checkups, participan
Sponsors
Kyoto University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Male taxi drivers aged between 20 and 70 years Individuals without a pacemaker or implantable cardioverter-defibrillator, and who can be safely measured using the InBody H30 Individuals with a BMI of 25 kg/m2 or higher, or a body fat percentage of 25% or higher as measured by the InBody H30
Exclusion criteria
Exclusion criteria: Individuals who are unable to use a smartphone Individuals with orthopedic or neurological conditions that prevent safe use of a bicycle Individuals experiencing chest pain, shortness of breath, palpitations, or joint pain in the lower limbs at rest Individuals who develop chest pain, shortness of breath, palpitations, or joint pain in the lower limbs during daily activities Individuals with implanted metal plates or similar devices Individuals currently undergoing cardiac rehabilitation Individuals with untreated grade three hypertension (systolic blood pressure >=180 mmHg and/or diastolic blood pressure >=110 mmHg), or symptomatic hypertension (with headache) Individuals with symptomatic heart disease (coronary artery disease, valvular disease, arrhythmias, heart failure) who have been advised by a physician to avoid exercise Individuals with other medical conditions that may be aggravated by physical activity Individuals who have been instructed by their primary care physician to restrict physical activity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in body fat percentage measured by InBody H30 between the start of the intervention and 90 days after the intervention begins. | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in lean body mass measured by InBody H30 between baseline and 90 days after the start of the intervention Difference in skeletal muscle mass measured by InBody H30 between baseline and 90 days after the start of the intervention Difference in BMI measured by InBody H30 between baseline and 90 days after the start of the intervention Difference in basal metabolic rate measured by InBody H30 between baseline and 90 days after the start of the intervention Difference in systolic blood pressure between baseline and 90 days after the start of the intervention Difference in LDL-C between baseline and 90 days after the start of the intervention Difference in HDL-C between baseline and 90 days after the start of the intervention Difference in Work Productivity and Activity Impairment (WPAI) scores between baseline and 90 days after the start of the intervention Difference in SF-12 scores between baseline and 90 days after the start of the intervention Difference in scores on the Japanese version of the Subjective Happiness Scale (SHS) between baseline and 90 days after the start of the intervention Difference in scores on the Interdependent Happiness Scale (IHS) between baseline and 90 days after the start of the intervention | — |
Countries
Japan
Contacts
Public ContactEri Kato
Kyoto University Hospital Department of Cardiology Center for Precision Medicine and Lifestyle-Related Disease Research
Outcome results
None listed